May 22, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 22, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that new data on the...
May 22, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 22, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that new data on the...
May 22, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 22, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that new data on the...
May 22, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 22, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that new data on the...
May 22, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 22, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that new data on the...
May 22, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 22, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that new data on the...
May 22, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 22, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that new data on the...